BR112014014692A2 - composição bioativa - Google Patents

composição bioativa

Info

Publication number
BR112014014692A2
BR112014014692A2 BR112014014692A BR112014014692A BR112014014692A2 BR 112014014692 A2 BR112014014692 A2 BR 112014014692A2 BR 112014014692 A BR112014014692 A BR 112014014692A BR 112014014692 A BR112014014692 A BR 112014014692A BR 112014014692 A2 BR112014014692 A2 BR 112014014692A2
Authority
BR
Brazil
Prior art keywords
bioactive composition
bioactive
serum fractions
composition
matricose
Prior art date
Application number
BR112014014692A
Other languages
English (en)
Other versions
BR112014014692B1 (pt
Inventor
Richards Jeanette
Jane Combs Mary
Koganov Michael
V Dueva-Koganov Olga
Dawson Tom
Original Assignee
Akzo Nobel Chemicals Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Chemicals Int Bv filed Critical Akzo Nobel Chemicals Int Bv
Publication of BR112014014692A2 publication Critical patent/BR112014014692A2/pt
Publication of BR112014014692B1 publication Critical patent/BR112014014692B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

resumo composição bioativa a presente invenção se refere a composições bioativas compreendendo misturas de frações de soro de camélia e matricária e/ou frações de soro de kelp e salsa.
BR112014014692-6A 2011-12-22 2012-12-19 composição bioativa BR112014014692B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161579197P 2011-12-22 2011-12-22
US61/579,197 2011-12-22
PCT/EP2012/076132 WO2013092699A2 (en) 2011-12-22 2012-12-19 Bioactive compositions having skin anti-aging activity

Publications (2)

Publication Number Publication Date
BR112014014692A2 true BR112014014692A2 (pt) 2017-06-13
BR112014014692B1 BR112014014692B1 (pt) 2019-01-29

Family

ID=47435961

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014014692-6A BR112014014692B1 (pt) 2011-12-22 2012-12-19 composição bioativa

Country Status (8)

Country Link
US (1) US10172784B2 (pt)
EP (1) EP2794032B1 (pt)
JP (1) JP5877457B2 (pt)
KR (1) KR20140107325A (pt)
CN (1) CN104010696B (pt)
BR (1) BR112014014692B1 (pt)
ES (1) ES2676185T3 (pt)
WO (1) WO2013092699A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013096736A2 (en) * 2011-12-22 2013-06-27 The Procter & Gamble Company Compositions and methods for treating skin
KR20140107301A (ko) * 2011-12-22 2014-09-04 아크조 노벨 케미칼즈 인터내셔널 비.브이. 모발 항노화 활성을 가진 생활성 조성물
KR102615332B1 (ko) * 2023-09-13 2023-12-20 (주)케이에이치케미칼 피버퓨 추출물을 포함하는 화장료 조성물

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2809971A (en) 1955-11-22 1957-10-15 Olin Mathieson Heavy-metal derivatives of 1-hydroxy-2-pyridinethiones and method of preparing same
US3236733A (en) 1963-09-05 1966-02-22 Vanderbilt Co R T Method of combatting dandruff with pyridinethiones metal salts detergent compositions
US3761418A (en) 1967-09-27 1973-09-25 Procter & Gamble Detergent compositions containing particle deposition enhancing agents
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US3753196A (en) 1971-10-05 1973-08-14 Kulite Semiconductor Products Transducers employing integral protective coatings and supports
US4345080A (en) 1980-02-07 1982-08-17 The Procter & Gamble Company Pyridinethione salts and hair care compositions
US4323683A (en) 1980-02-07 1982-04-06 The Procter & Gamble Company Process for making pyridinethione salts
US4379753A (en) 1980-02-07 1983-04-12 The Procter & Gamble Company Hair care compositions
US4470982A (en) 1980-12-22 1984-09-11 The Procter & Gamble Company Shampoo compositions
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
DE4118098C1 (pt) 1991-06-03 1992-05-27 Externa-Junika Kosmetikvertriebsgesellschaft Mbh, 7000 Stuttgart, De
FR2699818B1 (fr) 1992-12-24 1995-02-03 Oreal Composition cosmétique ou pharmaceutique contenant en association un polyphénol et un extrait de gingko.
JPH08217536A (ja) 1995-02-14 1996-08-27 Tdk Corp 正の抵抗温度係数を有する半導体磁器組成物及びその製造方法
JP2002020243A (ja) 2000-07-06 2002-01-23 Lion Corp 白髪防止・改善剤
CA2441025C (en) 2001-03-16 2011-08-16 Johnson & Johnson Consumer Companies, Inc. Composition containing feverfew extract and use thereof
JP2002332240A (ja) 2001-05-09 2002-11-22 Milbon Co Ltd 育毛剤組成物
EP1262167A1 (de) 2001-06-01 2002-12-04 Cognis France S.A. Kosmetische Zubereitungen enthaltend ein Extrakt von keimenden Pflanzen
US7442391B2 (en) * 2002-01-25 2008-10-28 Integrated Botanical Technologies, Llc Bioactive botanical cosmetic compositions and processes for their production
GB0220658D0 (en) * 2002-09-05 2002-10-16 Lorantis Ltd Immunotherapy
US20040175347A1 (en) 2003-03-04 2004-09-09 The Procter & Gamble Company Regulation of mammalian keratinous tissue using hexamidine compositions
US7320797B2 (en) 2003-08-29 2008-01-22 Bioderm Research Antiaging cosmetic delivery systems
EP1543823A1 (en) * 2003-12-19 2005-06-22 Johnson & Johnson Consumer France SAS Gingko containing formulations for the improvement of skin radiance
EP1543822A1 (en) 2003-12-19 2005-06-22 Johnson & Johnson Consumer France SAS Soy containing formulations for the improvement of skin radiance
CN1929851B (zh) 2004-01-12 2012-06-27 综合植物科技有限责任公司 得自山茶科植物的生物活性组合物及其生产方法和用途
JP2005296352A (ja) 2004-04-12 2005-10-27 Shiseido Co Ltd 白髪の評価方法
JP4685374B2 (ja) 2004-06-23 2011-05-18 株式会社ノエビア 皮膚外用剤
JP2006111544A (ja) 2004-10-13 2006-04-27 Shiseido Co Ltd 抗白髪剤
US20060275237A1 (en) 2005-05-09 2006-12-07 Bissett Donald L Skin care compositions containing idebenone
US20090123406A1 (en) 2005-12-13 2009-05-14 Stephen Pheiffer Organic therapeutic and cosmetic preparation
EP1991242B1 (en) 2006-02-21 2017-04-26 Isp Investment Inc. Parthenolide free bioactive ingredients from feverfew (tanacetum parthenium) and processes for their production
JP4470212B2 (ja) * 2006-11-11 2010-06-02 ビーエイチエヌ株式会社 皮膚改善剤
KR100937339B1 (ko) * 2007-07-20 2010-01-20 주식회사 코리아나화장품 동백꽃, 금은화, 이화, 회화, 백련화, 홍화 및 매화의 혼합 추출물로 구성된 칠화수를 포함하는 피부노화 방지용 화장료 조성물
US20100120871A1 (en) 2008-11-10 2010-05-13 Dawson Jr Thomas Larry Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair
CN101559181B (zh) * 2009-05-25 2011-11-09 齐苏雨 一种治疗高脂血症的药物及其制备方法
FR2946886B1 (fr) * 2009-06-17 2014-06-13 Ephyla Extrait de vegetal pour la fabrication de composition de controle de la melanogenese,composition de controle obtenue et procede de controle mettant en oeuvre une telle composition
ES2609785T3 (es) 2009-11-11 2017-04-24 Isp Investments Llc Fracciones bioactivas de organismos fotosintéticos inducidos por estrés y procedimientos para su fabricación y uso
US20110305737A1 (en) * 2010-06-09 2011-12-15 NY Derm LLC Multi-Active Microtargeted Anti-Aging Skin Cream Polymer Technology
KR20140107301A (ko) * 2011-12-22 2014-09-04 아크조 노벨 케미칼즈 인터내셔널 비.브이. 모발 항노화 활성을 가진 생활성 조성물
WO2013096736A2 (en) * 2011-12-22 2013-06-27 The Procter & Gamble Company Compositions and methods for treating skin

Also Published As

Publication number Publication date
CN104010696B (zh) 2017-05-31
US20140348766A1 (en) 2014-11-27
ES2676185T3 (es) 2018-07-17
CN104010696A (zh) 2014-08-27
KR20140107325A (ko) 2014-09-04
EP2794032B1 (en) 2018-06-06
WO2013092699A3 (en) 2014-01-03
US10172784B2 (en) 2019-01-08
BR112014014692B1 (pt) 2019-01-29
JP5877457B2 (ja) 2016-03-08
WO2013092699A2 (en) 2013-06-27
EP2794032A2 (en) 2014-10-29
JP2015500859A (ja) 2015-01-08

Similar Documents

Publication Publication Date Title
JOP20180102B1 (ar) مركب صيدلاني
CR20140404A (es) Concepto de recubrimiento novedoso
MX2020001159A (es) Composiciones y metodos que comprenden una variante de enzima lipolitica.
MX2018016021A (es) Composiciones y metodos que comprenden variante de enzima lipolitica.
PH12014502602B1 (en) Methods for improving safety of blood-brain barrier transport
CY1121560T1 (el) Ανοσογονικη συνθεση
EP3725811A3 (en) Compositions for inhibiting masp-2 dependent complement activation
BR112015010104A2 (pt) Variante de enzima termolisina, composição e método de limpeza
CR20140594A (es) Composiciones farmacéuticas y tratamiento de mastitis
IN2014DN08721A (pt)
BR112015001993A2 (pt) composição detergente
GT201200284A (es) Composición farmacéutica
MX2015006183A (es) Composicion lubricante.
WO2014080285A3 (en) Pharmaceutical compositions having improved storage stability
BR112015028565A2 (pt) Processos de pré-condicionamento de material e de produção de um produto
PH12014502860A1 (en) Racecadotril liquid compositions
BR112015027824A8 (pt) formulação de vitamina e na forma de pó
CL2013000426A1 (es) Composicion que comprende plasma rico en plaquetas de origen heterologo; y composicion farmaceutica y nutricional que la comprende.
AR082422A1 (es) Composicion detergente liquida
BR112013024914A2 (pt) composições de tingimento sólidas
BR112014032759A2 (pt) composições lipídicas de racecadotril
BR112015023387A2 (pt) composições lipídicas de racecodotril
TN2013000373A1 (en) Pharmaceutical formulation comprising inositol
BR112014005397A2 (pt) composições de aditivo de polietileno e artigos feitos do mesmo
BR112014014692A2 (pt) composição bioativa

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/12/2012, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 8A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2610 DE 12-01-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.